Price$5.98-0.36 (-5.68%)
01:30 PM04:00 PM
News · 26 weeks70+29%
2025-12-142026-06-07
Mix3390d
- SEC Filings14(42%)
- Other8(24%)
- Insider8(24%)
- Earnings2(6%)
- Leadership1(3%)
Latest news
25 items- INSIDERChairman and CEO Mann Paul Elliot was granted 2,233,555 shares and sold $2,004,337 worth of shares (251,275 units at $7.98) as part of a pre-agreed trading plan, increasing direct ownership by 26% to 9,579,845 units (SEC Form 4) (withholding tax)4 - ASP Isotopes Inc. (0001921865) (Issuer)
- INSIDERChief Financial Officer Kiessling Heather was granted 840,000 shares, increasing direct ownership by 118% to 1,549,376 units (SEC Form 4)4 - ASP Isotopes Inc. (0001921865) (Issuer)
- INSIDERChief Operating Officer Ainscow Robert was granted 800,000 shares, increasing direct ownership by 54% to 2,290,317 units (SEC Form 4)4 - ASP Isotopes Inc. (0001921865) (Issuer)
- INSIDEREVP, Gen Counsel, Secretary Ainscow Donald George was granted 400,000 shares, increasing direct ownership by 80% to 900,000 units (SEC Form 4)4 - ASP Isotopes Inc. (0001921865) (Issuer)
- SECSEC Form 144 filed by ASP Isotopes Inc.144 - ASP Isotopes Inc. (0001921865) (Subject)
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ASP Isotopes Inc. (0001921865) (Filer)
- PRASP Isotopes Implements Engineering Enhancements to Silicon-28 Enrichment Facility; Successfully Restarts First 18 Stages of Silicon-28 Enrichment Facility; Commercial Shipments of Enriched Silicon-28 Expected to Commence in Q3 2026ASP Isotopes has previously announced that it has signed three commercial contracts for the supply of enriched Silicon-28 to U.S.-based customers, and expects to make initial commercial shipments of enriched Silicon-28 in Q3 2026. The first 18 stages (comprising segments one and two) of the Silicon-28 enrichment facility have now successfully operated for over three weeks at target enrichment levels. Engineering modifications made over the past nine months addressed non-core components, including valves and compressors; these same engineering enhancements are expected to be implemented to the remaining stages of the enrichment facility to enable commercial production of enriched Silicon-2
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - ASP Isotopes Inc. (0001921865) (Filer)
- SECSEC Form 10-Q filed by ASP Isotopes Inc.10-Q - ASP Isotopes Inc. (0001921865) (Filer)
- SECSEC Form NT 10-Q filed by ASP Isotopes Inc.NT 10-Q - ASP Isotopes Inc. (0001921865) (Filer)
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ASP Isotopes Inc. (0001921865) (Filer)
- PRQuantum Leap Energy Enters into Memorandum of Understanding with European Nuclear Technology Company for Advanced Nuclear Fuel Supply CollaborationDALLAS, May 11, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI") today announced that Quantum Leap Energy LLC ("we," "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has entered into a non-binding Memorandum of Understanding (MOU) with a European nuclear technology company specializing in advanced nuclear reactor development and other next-generation nuclear energy solutions. "Securing reliable HALEU supply is one of the most critical challenges facing the advanced nuclear industry today. This MOU is a meaningful step in QLE's missi
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ASP Isotopes Inc. (0001921865) (Filer)
- PRQuantum Leap Energy Appoints Dr. Peter Fiske to Strategic Advisory BoardDALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI") today announced that Quantum Leap Energy LLC ("QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has appointed Dr. Peter S. Fiske to QLE's Strategic Advisory Board (SAB). "QLE is intentionally building the leadership, advisory depth, and execution discipline required to scale throughout government and commercial nuclear energy markets," said Dr. Ryno Pretorius, Chief Executive Officer of QLE. "Dr. Fiske brings firsthand experience from the highest levels of government en
- SECAmendment: SEC Form 10-K/A filed by ASP Isotopes Inc.10-K/A - ASP Isotopes Inc. (0001921865) (Filer)
- PRSkyline Builders Group Holding Ltd and Cove Kaz Capital Group LLC Announce Merger AgreementAcquisition of Largest Known Undeveloped Tungsten Resource Globally Export-Import Bank of the United States (EXIM) has issued a Letter of Interest for up to $900 million in financing as part of EXIM's Supply Chain Resiliency Initiative U.S. International Development Finance Corporation (DFC) has issued a Letter of Interest for up to $700 million for both debt financing and project development funding Combined company, named Kaz Resources Inc., to supply tungsten, rare earths and other critical minerals to the United States Kaz Resources Inc. expected to trade on Nasdaq under ticker symbol "KAZR" Skyline Builders Group Holding Limited ("Skyline" or "SKBL") (NASDAQ:SKBL) and C
- INSIDERSEC Form 4 filed by Ainscow Robert4 - ASP Isotopes Inc. (0001921865) (Issuer)
- INSIDERSEC Form 4 filed by Kiessling Heather4 - ASP Isotopes Inc. (0001921865) (Issuer)
- INSIDERSEC Form 4 filed by Moore Duncan4 - ASP Isotopes Inc. (0001921865) (Issuer)
- SECSEC Form 144 filed by ASP Isotopes Inc.144 - ASP Isotopes Inc. (0001921865) (Subject)
- INSIDERSEC Form 4 filed by Ainscow Robert4 - ASP Isotopes Inc. (0001921865) (Issuer)
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ASP Isotopes Inc. (0001921865) (Filer)
- PRASP Isotopes Inc. Provides Business UpdateFirst Commercial Shipments Expected Across Multiple Isotopes in 2026 Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026 EBITDA Target of Greater Than $300 Million in 2031 Cash, Cash Equivalents and Short-Term Marketable Securities of $333 million as of December 31, 2025 Business Update Conference Call Scheduled for 8:00 AM ET on April 13, 2026 DALLAS, April 13, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today provided a business update highlighting operational
- SECSEC Form 10-K filed by ASP Isotopes Inc.10-K - ASP Isotopes Inc. (0001921865) (Filer)
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ASP Isotopes Inc. (0001921865) (Filer)
ASPI FAQ
6 questionsWhere does ASPI stock trade?
ASP Isotopes Inc. (ASPI) is listed on NASDAQ.What sector and industry is ASPI in?
ASP Isotopes Inc. operates in the Industrials sector, Major Chemicals industry.When did ASP Isotopes Inc. go public?
ASP Isotopes Inc. (ASPI) completed its IPO in 2022.What are analysts saying about ASPI?
ASP Isotopes Inc. has had 3 recent analyst actions on file. The most recent action was from Cantor Fitzgerald: Overweight with a $1300.00 price target on 2025-12-04. Recent price targets range from $325.00 to $1300.00.What companies are similar to ASPI?
Notable peers in the same industry include LIN (Linde plc), APD (Air Products and Chemicals Inc.), DOW (Dow Inc.), LYB (LyondellBasell Industries NV), IFF (International Flavors & Fragrances Inc.). Compare ASPI side-by-side with any of them on Quantisnow.How can I track ASPI on Quantisnow?
Quantisnow aggregates ASP Isotopes Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ASPI to receive live email and push alerts on every new disclosure.